MoneyWorks4Me

Glenmark Pharmaceuticals informs about board meeting

27 Jul 2017 Evaluate

Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, Glenmark Pharmaceuticals has informed that Board has today at its meeting approved the Unaudited Financial Results for the First Quarter ended June 30, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..